: This study aimed to develop a new approach to manage people living with HIV (PLWH), investigating preferences of clinicians and PLWH in order to improve linkage to care of PLWH. A survey was performed with the Discrete Choice Experiment (DCE) method to investigate the preferences of two categories, clinicians and PLWH, for attributes of HIV care pathways, therapy and quality of life. Our results suggest that the most important feature of a care pathway was the site of testing for both categories, followed by modality of counselling for clinicians and by pre-exposure prophylaxis for PLWH. Regarding therapy, choices were mostly oriented by modality of administration for both categories, and by CD4 cells increase for clinicians and side effects for PLWH. People living with HIV reported that, out of 13 candidates, the two most important factors related to good long-term quality of life would be reduction of viral transmissibility and good emotional life. A tailored approach could be the key to long-term treatment success, but this approach must necessarily be based on evaluation of the specific complexities of the patient.

Preferences of PLWH and of clinicians for HIV treatment aimed at long-term success / Andreoni, Massimo; Antinori, Andrea; Castagna, Antonella; D'Arminio Monforte, Antonella; Di Perri, Giovanni; Mastroianni, Claudio; Mussini, Cristina; Rizzardini, Giuliano; Tavio, Marcello; Nozza, Silvia; Teti, Elisabetta; Corbelli, Giulio Maria; Pasqualetti, Patrizio. - In: NEW MICROBIOLOGICA. - ISSN 1121-7138. - 45:4(2022), pp. 308-319.

Preferences of PLWH and of clinicians for HIV treatment aimed at long-term success

Mussini, Cristina;Pasqualetti, Patrizio
2022

Abstract

: This study aimed to develop a new approach to manage people living with HIV (PLWH), investigating preferences of clinicians and PLWH in order to improve linkage to care of PLWH. A survey was performed with the Discrete Choice Experiment (DCE) method to investigate the preferences of two categories, clinicians and PLWH, for attributes of HIV care pathways, therapy and quality of life. Our results suggest that the most important feature of a care pathway was the site of testing for both categories, followed by modality of counselling for clinicians and by pre-exposure prophylaxis for PLWH. Regarding therapy, choices were mostly oriented by modality of administration for both categories, and by CD4 cells increase for clinicians and side effects for PLWH. People living with HIV reported that, out of 13 candidates, the two most important factors related to good long-term quality of life would be reduction of viral transmissibility and good emotional life. A tailored approach could be the key to long-term treatment success, but this approach must necessarily be based on evaluation of the specific complexities of the patient.
2022
45
4
308
319
Preferences of PLWH and of clinicians for HIV treatment aimed at long-term success / Andreoni, Massimo; Antinori, Andrea; Castagna, Antonella; D'Arminio Monforte, Antonella; Di Perri, Giovanni; Mastroianni, Claudio; Mussini, Cristina; Rizzardini, Giuliano; Tavio, Marcello; Nozza, Silvia; Teti, Elisabetta; Corbelli, Giulio Maria; Pasqualetti, Patrizio. - In: NEW MICROBIOLOGICA. - ISSN 1121-7138. - 45:4(2022), pp. 308-319.
Andreoni, Massimo; Antinori, Andrea; Castagna, Antonella; D'Arminio Monforte, Antonella; Di Perri, Giovanni; Mastroianni, Claudio; Mussini, Cristina; Rizzardini, Giuliano; Tavio, Marcello; Nozza, Silvia; Teti, Elisabetta; Corbelli, Giulio Maria; Pasqualetti, Patrizio
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1296650
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 0
social impact